Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;72(3):253-7.
doi: 10.1016/j.mjafi.2016.06.004. Epub 2016 Aug 9.

Development of vascular complications and bladder carcinoma in diabetics using pioglitazone: A five-year Indian review

Affiliations

Development of vascular complications and bladder carcinoma in diabetics using pioglitazone: A five-year Indian review

Saarwaani Vallabhajosyula et al. Med J Armed Forces India. 2016 Jul.

Abstract

Background: Pioglitazone has better cardiovascular outcomes and a questionable relationship with bladder carcinoma in diabetes mellitus, type II (DM-2). We sought to evaluate the role of pioglitazone in the Indian population.

Methods: This is a retrospective study at an academic medical center in India. All DM-2 patients in 2008 with a new prescription of pioglitazone were age- and gender-matched with non-users. We excluded patients with gestational DM or DM type I. They were followed forward for five years and demographic data, micro- and macro-vascular complications, mortality, and bladder carcinoma were recorded. Two-tailed p ≤ 0.05 was considered statistically significant.

Results: Two cohorts of 260 patients, with mean age of 58 ± 11 years with 413 (79.4%) males, were followed for five years. Pioglitazone users had higher hypertension, obesity, DM-2 family history (all p < 0.003), and use of insulin and oral hypoglycemics (all p < 0.0001) in comparison to non-users. HbA1c was not different between groups. Over five years, pioglitazone users had lesser retinopathy and myocardial infarctions (all p < 0.01). Five cases of bladder carcinoma were noted, all in the pioglitazone group, however without statistical significance. Baseline variables, including mean daily pioglitazone dose, were not statistically different between patients with and without bladder carcinoma. Nephropathy and MI were independent predictors for development of bladder carcinoma within pioglitazone users.

Conclusions: Pioglitazone users had significantly lesser myocardial infarctions and retinopathy despite more difficult to control DM 2. In an age- and gender-matched cohort of users and non-users, pioglitazone did not contribute to development of bladder cancer in the Indian population.

Keywords: Bladder carcinoma; Diabetes mellitus type-2; Pioglitazone; Thiazolidinedione; Vascular complications.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Kaplan–Meier curve for occurrence of bladder carcinoma over five years.

Similar articles

Cited by

References

    1. Levin D., Bell S., Sund R. Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis. Diabetologia. 2015;58(March (3)):493–504. - PubMed
    1. Zou C., Hu H. Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk. Vasc Health Risk Manag. 2013;9:429–433. - PMC - PubMed
    1. Nissen S.E., Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356(24):2457–2471. - PubMed
    1. Ryder R.E., Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit Diabet Med. 2015;32(March (3)):305–313. - PubMed
    1. Lu C.J., Sun Y., Muo C.H., Chen R.C., Chen P.C., Hsu C.Y. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study. Cerebrovasc Dis. 2013;36(2):145–151. - PubMed

LinkOut - more resources